https://scholars.lib.ntu.edu.tw/handle/123456789/593951
Title: | Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD) | Authors: | Shi, Qiang KO-JEN LI Treuer, Tamas Wang, Bruce C M Gaich, Carol L Lee, Chien-Hsun Wu, Wen-Shuo Furnback, Wesley Tang, Chao-Hsiun |
Keywords: | RISK; PREVALENCE; COMORBIDITY; MANIFESTATIONS; OSTEOPOROSIS; CONSORTIUM; MORTALITY; FREQUENCY; FRACTURE; PEOPLE | Issue Date: | 6-Apr-2018 | Publisher: | PUBLIC LIBRARY SCIENCE | Journal Volume: | 13 | Journal Issue: | 4 | Start page/Pages: | e0193489 | Source: | PloS one | Abstract: | Previous studies in Taiwan utilizing the Taiwan's National Health Insurance Database (NHIRD) have estimated the direct healthcare costs of RA patients, but they have not focused on patients on bDMARDs, or considered patients' response to therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/593951 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0193489 | SDG/Keyword: | disease modifying antirheumatic drug; glucocorticoid; adalimumab; antirheumatic agent; biological product; etanercept; adult; algorithm; Article; data base; disease burden; female; follow up; health care cost; health care utilization; health economics; human; longitudinal study; major clinical study; male; medication compliance; national health insurance; retrospective study; rheumatoid arthritis; Taiwan; treatment response; cost of illness; economics; factual database; health care cost; insurance; middle aged; public health; rheumatoid arthritis; treatment outcome; very elderly; Adalimumab; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cost of Illness; Databases, Factual; Etanercept; Female; Health Care Costs; Humans; Insurance Claim Review; Male; Middle Aged; National Health Programs; Retrospective Studies; Taiwan; Treatment Outcome |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.